Guillain-Barré Syndrome in COVID-19: A Probable Association
DOI:
https://doi.org/10.3126/jbpkihs.v7i2.63832Keywords:
COVID-19, Guillain–Barré Syndrome, NepalAbstract
Guillain–Barré syndrome (GBS) is characterized by areflexia, albuminocytologic dissociation and progressive motor weakness. It has been associated with preceding viral infections. We report a case suggestive of a possible link between GBS and prior COVID-19 infection. A 20-year-old female from Dhankuta, with a history of COVID-19 infection diagnosed one month earlier, presented to the emergency department at B.P. Koirala Institute of Health Sciences (BPKIHS) with a two-day history of ascending paralysis. Based on the Brighton Criteria, a clinical diagnosis of GBS was suspected. In the context of the COVID-19 pandemic, GBS associated with SARS-CoV-2 infection should be carefully differentiated from other causes of neuropathy and myopathy. A high index of suspicion is essential for timely diagnosis and management.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Journal of BP Koirala Institute of Health Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.